dalteparin has been researched along with Aortic Arteritis, Giant Cell in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szydełko-Paśko, U | 1 |
| Przeździecka-Dołyk, J | 1 |
| Kręcicka, J | 1 |
| Małecki, R | 1 |
| Misiuk-Hojło, M | 1 |
| Turno-Kręcicka, A | 1 |
| Assad, M | 1 |
| Coffin-Pichonnet, S | 1 |
| Billotte, C | 1 |
| Denion, É | 1 |
2 other studies available for dalteparin and Aortic Arteritis, Giant Cell
| Article | Year |
|---|---|
Arteritic Anterior Ischemic Optic Neuropathy in the Course of Giant Cell Arteritis After COVID-19.
Topics: Aged; COVID-19; Enoxaparin; Female; Giant Cell Arteritis; Humans; Optic Neuropathy, Ischemic; SARS-C | 2022 |
[Acute unilateral arteritic anterior ischemic optic neuropathy becoming bilateral despite corticosteroid therapy].
Topics: Acute Disease; Aged; Alzheimer Disease; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Disease P | 2016 |